Sung-Bae Kim, MD, PhD, Professor/Dept of Oncology

Form 483

Seoul, -, Korea (the Republic of)FEI 3009399570Issued April 13, 2012

View FDA's Record for This Firm

Source: FDA inspection record. Confirmed against FDA's published inspection data for this establishment and inspection date. FDA has published the inspection and what it cited, but not the form itself, which usually takes six to twelve months. To check it, open FDA's record for this establishment on FDA's Data Dashboard, listed under FEI 3009399570.

Observations1

Issue DateApril 13, 2012

StatusNo Warning Letter

Related Inspections2

Establishment Details

Firm: Sung-Bae Kim, MD, PhD, Professor/Dept of Oncology
Location: Seoul, -, Korea (the Republic of)
FEI Number: 3009399570
Product Type: Drugs
Issue Date: April 13, 2012
Country: Korea (the Republic of)

Inspection History, 2012 to 2017

NAI1

VAI1

NAI means No Action Indicated. VAI means Voluntary Action Indicated.

Act on This Form 483

FDA Inspection ReadinessSee how your operations would hold up to the same scrutiny.CAPA & InvestigationsScore how you would investigate and close findings like these.Talk to a SpecialistWalk through these observations with a ComplianceQuest expert.

Sung-Bae Kim, MD, PhD, Professor/Dept of Oncology FDA Form 483, Seoul, April 13, 2012